The International Money Express, Inc. 2020 Omnibus Equity Compensation Plan (the “2020 Plan”) provided for the granting of stock-based incentive awards, including stock options, restricted stock units (“RSUs”), restricted stock awards (“RSAs”) and performance stock units (“PSUs”) to employees, certain service providers and independent directors of the Company. There were 3.7 million shares of the Company’s common stock approved for issuance under the 2020 Plan, which included 0.4 million shares that were previously subject to awards granted under the International Money Express, Inc. 2018 Omnibus Equity Compensation Plan (the “2018 Plan”). Although awards remain outstanding under the 2018 Plan, which was terminated effective June 26, 2020, no additional awards may be granted under the 2018 Plan.

On June 20, 2025, the Company’s stockholders approved the Amended and Restated International Money Express, Inc. 2020 Omnibus Equity Compensation Plan (the “A&R 2020 Plan” and together with the 2018 and 2020 Plans, the “Plans”), which amends and restates the 2020 Plan. The A&R 2020 Plan increased the number of shares of common stock authorized for issuance under the 2020 Plan by an additional 2.5 million shares. As of March 31, 2026, 2.8 million shares remained available for future awards under the Plan.

The value of each option grant is estimated on the grant date using the Black-Scholes option pricing model (“BSM”). The option pricing model requires the input of certain assumptions, including the grant date fair value of our common stock, expected volatility, risk-free interest rates, expected term and expected dividend yield. To determine the grant date fair value of the Company’s common stock, we use the closing market price of our common stock at the grant date. We also use an expected volatility based on the historical volatility of the Company’s common stock and the “simplified” method for calculating the expected life of our stock options as the options are “plain vanilla” and we do not have any significant historical post-vesting activity. We have elected to account for forfeitures as they occur. The risk-free interest rates are obtained from publicly available U.S. Treasury yield curve rates.

Share-based compensation is recognized as an expense on a straight-line basis over the requisite service period, which is generally the vesting period. The stock options issued under the Plans have 10-year terms and generally vest in four equal installments beginning one year after the date of the grant. The Company recognized no compensation expense for stock options for both the three months ended March 31, 2026 and 2025, respectively. As of March 31, 2026, there is no unrecognized compensation expense related to stock options.


	Number of Options	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (Years)	Weighted-Average Grant Date Fair Value
Outstanding at December 31, 2025	146,125	$	12.21	3.38	$	4.38
Granted	—	$	—		$	—
Exercised	—	$	—		$	—
Forfeited	—	$	—		$	—
Expired	—	$	—		$	—
Outstanding at March 31, 2026	146,125	$	12.21	3.14	$	4.38

Exercisable at March 31, 2026(1)	146,125	$	12.21	3.14	$	4.38

(1) The aggregate fair value of all vested/exercisable options outstanding as of March 31, 2026 was $0.6 million, which was determined based on the market value of our stock as of that date.

The RSUs granted under the Plans to the Company’s employees or certain service providers generally vest in four equal annual installments beginning one year after the date of the grant, while RSUs issued to the Company’s independent directors generally vest on the one-year anniversary from the grant date. The Company recognized compensation expense for all RSUs of approximately $1.2 million and $0.9 million for the three months ended March 31, 2026 and 2025, respectively, which is included in salaries and benefits in the condensed consolidated statements of income and comprehensive income. As of March 31, 2026, unrecognized compensation expense related to RSUs of approximately $11.2 million is expected to be recognized over a weighted-average period of 2.0 years.


	Number of RSUs	Weighted-Average Grant Price
Outstanding (nonvested) at December 31, 2025	591,538	$	17.17
Granted(1)	336,969	$	15.55
Vested	(129,760)	$	18.90
Forfeited	(5,889)	$	15.07
Outstanding (nonvested) at March 31, 2026	792,858	$	16.21

The RSAs issued under the A&R 2020 Plan to the Company’s employees generally vest in four equal annual installments beginning one year after the date of grant, while RSAs issued to certain of the Company’s independent directors vest at the end of the three-month calendar quarter in which the grant is made (or, if earlier, upon the consummation of a change in control). The Company recognized compensation expense for RSAs granted of $0.6 million and $0.5 million for the three months ended March 31, 2026 and 2025, respectively, which is included in salaries and benefits in the condensed consolidated statements of income and comprehensive income. As of March 31, 2026, there was $7.6 million of unrecognized compensation expense related to RSAs, which is expected to be recognized over a weighted-average period of 2.1 years.


	Number of RSAs	Weighted-Average Grant Price
Outstanding (nonvested) at December 31, 2025	257,169	$	20.12
Granted(1)	301,957	$	15.55
Vested	(99,015)	$	19.96
Forfeited	—	$	—
Outstanding (nonvested) at March 31, 2026	460,111	$	17.16

(1) The aggregate fair value of all RSAs granted during the three months ended March 31, 2026 was approximately $4.7 million, which was determined based on the market value of our stock as of that date.

PSUs granted under the A&R 2020 Plan to the Company’s employees generally vest subject to attainment of performance criteria during the service period established by the Compensation Committee. Each PSU represents the right to receive one share of common stock, and the actual number of shares issuable upon vesting is determined based upon performance compared to financial performance targets. The PSUs vest based on the achievement of certain adjusted earnings per share targets for a period of up to three years combined with a service period of three years. Compensation cost is recognized over the requisite service period when it is probable that the performance condition will be satisfied.

The Company recognized compensation expense for PSUs of $0.7 million and $0.3 million for the three months ended March 31, 2026 and 2025, respectively, which is included in salaries and benefits in the condensed consolidated statements of income and comprehensive income. As of March 31, 2026, there was $3.5 million of unrecognized compensation expense related to PSUs, which is expected to be recognized over a weighted-average period of 1.5 years.


	Number of PSUs	Weighted-Average Remaining Contractual Term (Years)	Weighted-Average Grant Price
Outstanding (nonvested) at December 31, 2025	506,942	8.56	$	14.70
Granted	—		$	—
Vested/accelerated	—		$	—
Forfeited	—		$	—
Outstanding (nonvested) at March 31, 2026	506,942	8.66	$	14.70